Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 9, 2008
Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone
Akihiro Yano, Shinji Tsutsumi, Shiro Soga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 4, 2012
Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response
Stéphanie Solier, Kurt W Kohn, Bradley Scroggins, et al.
Oncology Letters
|
December 2, 2015
Alterations of immune cell subsets in relapsed, thymoma-associated minimal change disease: A case report
Helen Gharwan, Yusuke Tomita, Min-Jung Lee, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
June 22, 2006
Curcumin is an inhibitor of p300 histone acetylatransferase
Monica G Marcu, Yun-Jin Jung, Sunmin Lee, et al.
Cancer Research
|
November 25, 2003
The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells
Wanping Xu, Xitong Yuan, Yun Jin Jung, et al.
Expert Review of Hematology
|
April 28, 2017
The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury
Pedro Cabrales, Scott Caroen, Arnold Oronsky, et al.
Cancer Chemotherapy and Pharmacology
|
May 9, 2003
Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug
Martin J Edelman, Kenneth Bauer, Shyam Khanwani, et al.
Molecular Pharmacology
|
September 4, 2010
Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma
Hye-Sik Kong, Sunmin Lee, Kristin Beebe, et al.
Plos One
|
October 23, 2013
Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects
Dror Luger, Yu-An Yang, Asaf Raviv, et al.
Trends in Cancer
|
April 30, 2020
MGMT Status as a Clinical Biomarker in Glioblastoma
Madison Butler, Lorinc Pongor, Yu-Ting Su, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Proceedings of the National Academy of Sciences of the United States of America
|
October 9, 2008
Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone
Akihiro Yano, Shinji Tsutsumi, Shiro Soga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 4, 2012
Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response
Stéphanie Solier, Kurt W Kohn, Bradley Scroggins, et al.
Oncology Letters
|
December 2, 2015
Alterations of immune cell subsets in relapsed, thymoma-associated minimal change disease: A case report
Helen Gharwan, Yusuke Tomita, Min-Jung Lee, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
June 22, 2006
Curcumin is an inhibitor of p300 histone acetylatransferase
Monica G Marcu, Yun-Jin Jung, Sunmin Lee, et al.
Cancer Research
|
November 25, 2003
The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells
Wanping Xu, Xitong Yuan, Yun Jin Jung, et al.
Expert Review of Hematology
|
April 28, 2017
The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury
Pedro Cabrales, Scott Caroen, Arnold Oronsky, et al.
Cancer Chemotherapy and Pharmacology
|
May 9, 2003
Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug
Martin J Edelman, Kenneth Bauer, Shyam Khanwani, et al.
Molecular Pharmacology
|
September 4, 2010
Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma
Hye-Sik Kong, Sunmin Lee, Kristin Beebe, et al.
Plos One
|
October 23, 2013
Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects
Dror Luger, Yu-An Yang, Asaf Raviv, et al.
Trends in Cancer
|
April 30, 2020
MGMT Status as a Clinical Biomarker in Glioblastoma
Madison Butler, Lorinc Pongor, Yu-Ting Su, et al.
Page
of 5